Report explores the Biopharmaceuticals Contract Manufacturing Market likely to emerge over a period of 2027

Publisher: The Insight Partners

According to The Insight Partners market research study of ‘Biopharmaceuticals Contract ManufacturingMarketto 2027 – Global Analysis and Forecasts by Product, and Service.’ The global biopharmaceuticals contract manufacturingmarket is expected to reach US$ 25,497.26Mn in 2027 from 13,727.13Mn in 2019. The market is estimated to grow with a CAGR of 8.2% from 2020-2027. The report provides trends prevailing in the global biopharmaceuticals contract manufacturing marketand the factors driving market along with those that act as hindrances.

The global biopharmaceuticals contract manufacturing market, based on the product, is segmented into biologics and biosimilars.The biologicssegment held the largest share of the market in 2019. Whereas, the biosimilar segment is estimated to register the highest CAGR in the market during the forecast period owing to increasing demand of biologics, increasing research activities in niche markets and growing biologics pipeline. Moreover, many big pharmaceutical companies prefer contract manufacturers to scale up their production and manage operating expenses.

The biopharmaceuticals contract manufacturing market is expected to grow, owing to the increasing outsourcing by pharmaceutical companies, growing biologics pipeline and growth in emerging markets. However, increasing competition among contract manufacturers is expected to restraint the growth of the market during the forecast years.

Leading companies operating in the biopharmaceuticals contract manufacturing marketare Lonza Group AG, Boehringer Ingelheim International GmbH, Inno Biologics Ventures Sdn Bhd,Thermo Fisher Scientific, AbbVie Inc., and WuXi Biologics, General Electric, Samsung Biologics, Merck KGaA, Ajinomoto Co., Inc. among others.

Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.theinsightpartners.com/sample/TIPRE00005512/

Global Biopharmaceuticals Contract Manufacturing Market – By Product

• Biologics
  • Monoclonal Antibodies
  • Recombinant Proteins
  • Vaccines
  • Others
• Biosimilars

Global Biopharmaceuticals Contract Manufacturing Market – By Service

• Development Process
• Final Dosage Operation
• Analytical and Quality Control
• Final Packaging

Biopharmaceuticals Contract Manufacturing Market– By Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • Italy
  • UK
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
  • Rest of Asia Pacific
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
• South America
  • Brazil
  • Argentina
  • Rest of South America

Company Profiles

• Lonza Group AG
• Boehringer Ingelheim International GmbH
• Inno Biologics Ventures Sdn Bhd
• Thermo Fisher Scientific
• AbbVie Inc.
• WuXi Biologics
• General Electric
• Samsung Biologics
• Merck KGaA
• Ajinomoto Co., Inc

Purchase a copy of this research report @ https://www.theinsightpartners.com/buy/TIPRE00005512/

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:

Call: +1-646-491-9876

Email: sales@theinsightpartners.com